The clock is ticking for pharmaceutical companies as the September 29 deadline for most favored nation pricing plans looms just 47 days away. This sweeping policy shift represents one of the most significant potential pricing reforms in recent...
The clock is ticking for pharmaceutical companies as the September 29 deadline for most favored nation pricing plans looms just 47 days away. This sweeping policy shift represents one of the most significant potential pricing reforms in recent...